TAE226, a Bis-Anilino Pyrimidine Compound, Inhibits the EGFR-Mutant Kinase Including T790M Mutant to Show Anti-Tumor Effect on EGFR-Mutant Non-Small Cell Lung Cancer Cells

Hiroki Otani(Shimane University), Shinichi Toyooka(Okayama University Hospital)

PLoS ONE

June 19, 2015

10.1371/journal.pone.0129838

Cited by 10

Related Papers

Immune evasion through mitochondrial transfer in the tumour microenvironment

|Nature|2025|239

Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features

|Scientific Reports|2017|60

Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer

|PLoS ONE|2017|41

Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer

|Oncology Letters|2017|28

Anti-Cancer Effects of REIC/Dkk-3-encoding Adenoviral Vector for the Treatment of Non-small Cell Lung Cancer

|PLoS ONE|2014|27